Quiz collegato alla guida · Medio Livello

AI in Prostate Cancer MRI Quiz

Tests AI support for prostate MRI, PI-RADS context, study generalizability, clinical review, and patient-centered follow-up.

Percorsi guida correlatiAI In Prostate Cancer Mri
Domanda 1 di 8

Cosa può contribuire l’intelligenza artificiale all’interpretazione della risonanza magnetica della prostata?

Anteprima di ogni domanda8 domande

Le risposte e le spiegazioni vengono visualizzate mentre rispondi al quiz.

  1. Cosa può contribuire l’intelligenza artificiale all’interpretazione della risonanza magnetica della prostata?
    • Confirm cancer without pathology or clinical context
    • Choose a biopsy treatment plan automatically
    • Replace all MRI sequences with one image score
    • Localize candidate lesions or support risk assessment for clinician review
  2. Cosa fornisce PI-RADS nella risonanza magnetica della prostata?
    • A guarantee that a detected lesion is malignant
    • A laboratory quality-control requirement
    • A structured framework radiologists use to describe and assess findings
    • A genetic variant classification standard
  3. Perché la validazione prospettica è utile dopo un promettente studio sull’intelligenza artificiale con risonanza magnetica?
    • It guarantees improved patient outcomes
    • It tests whether performance transfers to real clinical workflows and populations
    • It proves the model will work on every scanner
    • It removes the need for a reference standard
  4. Quali evidenze dovrebbero essere utilizzate per valutare la MRI AI della prostata?
    • Pathology or well-defined follow-up, with relevant sensitivity and specificity measures
    • Solo la perdita di allenamento del modello
    • The number of highlighted pixels
    • The clinician’s preferred image viewer
  5. Perché un test retrospettivo arricchito può sopravvalutare le prestazioni?
    • It has too many MRI sequences to interpret
    • Pathology cannot be used as a reference
    • It automatically represents every clinic
    • Its patient mix may differ from the population and prevalence where the tool will be used
  6. How should a patient interpret an AI-highlighted prostate lesion?
    • As a treatment recommendation from the model
    • As a finding for radiologist and clinician assessment, not a diagnosis
    • As proof that cancer is present
    • As proof that biopsy is unnecessary
  7. What information should accompany a prostate MRI AI audit?
    • Scanner and sequence protocol, software version, reader interaction, and follow-up outcomes
    • Only the radiologist’s initials
    • The model’s color palette
    • The patient’s unrelated billing history
  8. Which decision belongs in shared clinical decision-making?
    • The scan score overriding patient preference
    • A software update setting the biopsy threshold without review
    • Whether AI findings, PSA, history, and other evidence support biopsy or follow-up
    • The model alone deciding treatment